Indication

Inflammatory bowel disease

Inflammatory bowel disease is an umbrella term for chronic, immune-mediated inflammatory disorders of the gastrointestinal tract, primarily encompassing Crohn's disease and ulcerative colitis. Read more about Inflammatory bowel disease

334 drugs 161 manufacturers

Advertisement

Drugs that treat it

Common Inflammatory bowel disease therapies.

Showing 163–171 of 334 drugs

PREDNISOLONE

GLUCOCORTICOSTEROIDS·TRICHINOSIS·+59
PHARMACEU ASSOC
Filter & compare in the drug finder →Opens the drug finder with Inflammatory bowel disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Inflammatory bowel disease.

Inflammatory bowel disease is an umbrella term for chronic, immune-mediated inflammatory disorders of the gastrointestinal tract, primarily encompassing Crohn's disease and ulcerative colitis.

The condition arises from an inappropriate, dysregulated immune response to intestinal microbiota in genetically susceptible individuals, leading to epithelial barrier breakdown and persistent mucosal damage.

It can affect pediatric and adult populations, running a relapsing and remitting course clinically characterized by abdominal pain, persistent diarrhea, rectal bleeding, weight loss, and fatigue.

Pathophysiologically, ulcerative colitis produces continuous mucosal inflammation confined to the colon and rectum, whereas Crohn's disease causes transmural, discontinuous inflammation that can manifest anywhere along the digestive tract.

Personalize your experience

Follow Inflammatory bowel disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it